Join our antibody CMC & regulatory experts Jeffrey Mocny, Gavin Murdoch & Sudha Krishnan at the upcoming PBSS San Francisco Forum event on February 19th to discuss the fundamentals, best practices, and regulatory strategies of antibody therapeutics.

Event Summary

This workshop will cover all key functions of Chemistry, Manufacturing and Control (CMC) of recombinant protein and antibody therapeutics. Designed for both experts seeking cross-functional insights and new entrants from academia or industry, it will provide a clear understanding of how all CMC functions connect. The attendees will gain knowledge of the current best practices and emerging trends across the CMC landscape—from process and analytical development to formulation, manufacturing, and regulatory considerations. Subject-matter experts will share their real-world experiences and provide their perspectives on future practices. Join us to strengthen your CMC knowledge, broaden your perspective, and network with peers shaping the future of biotherapeutic development.

Key Topics Include:

• Generation of production cell line and cell banking,
• Upstream Process Development,
• Downstream Process Development,
• Analytical Development,
• Drug substance production and scale-up,
• Formulation and drug product development,
• Regulatory CMC and Quality Assurance.

Schedule a Meeting with Our Experts at the Event